Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ephrin-B2 is a cell surface transmembrane ligand encoded by the EFNB2 gene. It belongs to the ephrin-B class and primarily interacts with Eph receptors, a family of receptor tyrosine kinases. Ephrin-B2 plays crucial roles in angiogenesis by regulating endothelial cell proliferation, migration, and vessel remodeling. It mediates bidirectional signal transduction—acting as both ligand and signaling molecule itself. In the context of disease, ephrin-B2 is associated with several processes including cancer progression, neural development, and cardiovascular homeostasis. Additionally, ephrin-B2 serves as a functional cell entry receptor for Hendra and Nipah viruses. Due to its central role in multiple essential biological pathways, ephrin-B2 is a recognized therapeutic target, but efforts to modulate its activity must carefully consider potential systemic effects and safety challenges[1][2][3][4][6].
Antagonism of Eph/ephrin interaction—blocking ligand-receptor binding and downstream signal transduction[3]; Inhibition of angiogenesis by disrupting Ephrin-B2/Eph receptor signaling[1]; Blocking viral entry (potential application for inhibitors in Hendra/Nipah viral infection)[2][3]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ephrin-B2.